Health insurer Cigna reports better-than-expected profit

Go back to Health insurer Cigna reports better-than-expected profit

UBS Reiterates Buy on Cigna Corp. (CI) Following 3Q

November 9, 2015 10:54 AM EST

UBS reiterated a Buy rating on CIGNA (NYSE: CI), and cut the price target to $172.00 (from $175.00), following the company's 3Q earnings report. For 2016, Cigna expects to maintain its public exchange footprint. Cigna participated in limited markets in eight states for 2015, and the company is... More

Positive Operating Execution and SG&A Improvement Drives EPS Beat For Cigna Corp. (CI); Wedbush Remains Neutral

November 9, 2015 8:01 AM EST

Wedbush maintained a Neutral rating on CIGNA (NYSE: CI), and cut the price target to $175.00 (from $186.00), following the company's 3Q15 earnings report. Adjusted EPS of $2.28, vs. consensus of $2.20, was driven by positive operating execution with better than expected SG&A improvement. 2015 EPS guidance was raised to $8.40-8.60 from $8.30-8.60 vs. consensus of $8.62.

Analyst Sarah James commented, "Adjusted EPS of $2.28 vs.... More

Cigna (CI) Tops Q3 EPS by 8c; Updates FY15 EPS Outlook

November 6, 2015 8:54 AM EST

Cigna (NYSE: CI) reported Q3 EPS of $2.28, $0.08 better than the analyst estimate of $2.20. Revenue for the quarter came in at $9.4 billion versus the consensus estimate of $9.51 billion.

Cigna sees FY2015 EPS of $8.40-$8.60, versus the consensus of $8.62.

For earnings history and earnings-related data on Cigna (CI) click here.

... More